Dr Lalchandani Labs IPO – Review, Allotment Status, Subscription, Price, Date & more

Dr Lalchandani Labs IPO is a new IPO launching on 25th April 2017. Dr Lalchandani Labs Limited, a diagnostic & healthcare service providers for the diagnosis and treatment of diseases, is all set to float an IPO. Lets have a detailed review of Dr Lalchandani Labs IPO & in-depth analysis of its IPO release date, IPO offer price, Dr Lalchandani Labs IPO subscription, IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.


Dr Lalchandani Labs IPO Review & Ratings

Dr Lalchandani Labs IPO Ratings & Review
CriteriaRatings
Industry Sentiments6.1/10
Industry Ranking6.4/10
Company Background6.2/10
Company Reputation6.3/10
Competitive Edge6.3/10
Financial Statements6.2/10
Popularity Index6.4/10
Promoters Reputation6.2/10
Retail Appetite6.3/10
Top Brokers Review6.3/10
Overall Ratings6.3/10
Star Ratings★★★☆☆

Summary of Dr Lalchandani Labs IPO

Dr Lalchandani Labs IPODr Lalchandani Labs Ltd, the company is 3 decades old and provides its services that are related to pathology, Hospital lab management, blood bank, doctor consultation and corporate health checks.

This company runs a chain of diagnostic Laboratories in Delhi / NCR. They do all kind of pathological and genetical investigation in different branches of Life Science. Example – virology, microbiology, immunology, histopathology, biochemistry, cytology, immunoassay, etc.

Dr Lalchandani Labs Ltd provides wide range of diagnostic assessments for patients and also regular health checkup for employees of corporate companies. The company is equipped with highly advanced and fully automated machines. Dr Lalchandani Labs Ltd also has 5 diagnostic Labs in Delhi and multiple collection centers across Delhi/NCR.

The company is open for an IPO with 1,400,000 equity shares of Rs. 10 each at a fixed price of Rs30 per equity share to generate Rs 4.20 crore. The company needs this. In order to repair debt, purchase of diagnostic equipment and machines, open more collection centers and other it support and operational expenses.

The Promoters of the Company:

  • Mr. Arjan Lal Chandani,
  • Mr. Mohit Lal Chandani, and
  • Mrs. Anchal Gupta

Dr Lalchandani Labs Limited has appointed one Lead Manager i.e. Navigant Corporate Advisors Ltd. The registrar to the offer is Cameo Corporate Services Limited.


Subscribe to Dr Lalchandani Labs IPO

Fill the Details Below
  1. Subscribe to IPOOpen Demat AccountBecome Sub Broker

Dr Lalchandani Labs IPO Date

The release date of the issue date of the IPO is 25th April 2018 & closing day of the issue is 27th April 2018.

Dr Lalchandani Labs IPO Subscription

 Subscription
Day 1X
Day 2X
Day 3X
Day 4X
Day 5X

The details about subscription would be updated post the release of the IPO.

Dr Lalchandani Labs IPO Allotment Status

The allotment status section gives information regarding the extent to which he shares have been allotted to the subscribers. Thus, the details of subscription and allotment would be updated post the release of IPO.

Dr Lalchandani Labs IPO Price Band

The face value of each equity share is Rs.10 but the price band of the IPO is Rs. 30 per shares i.e. at Rs. 20 premium.

Dr Lalchandani Labs IPO Issue Size

The Issue size of Dr Lalchandani Labs IPO is up to Rs 3.98 crore and 1328000.00 [email protected]/share with minimum order quantity of 4000 shares.

Dr Lalchandani Labs IPO Equity Share Offerings

The equity shares in the offering is around 18,00,000 shares of which 90,000 equity shares are reserved for market makers while 17,90,000 shares are up for net issue to the public.


Dr Lalchandani Labs Limited – Company Overview

Dr. Lalchandani Labs was originally incorporated as partnership firm at New Delhi vide Partnership Agreement dated 15th Day of September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited incorporated under the provisions of Companies Act, 2013 vide certificate of Incorporation dated 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Corporate Identification Number of the Company is U85320DL2017PLC321605. For further details of incorporation, change of name and registered office of our Company, please refer to chapter titled “General Information” and “Our History and Corporate Structure” beginning on page 47 and page 137 respectively of this Draft Prospectus. The company is open for an IPO with 1,400,000 equity shares of Rs. 10 each at a fixed price of Rs30 per equity share to generate Rs 4.20 crore.

Registered Office:

M-20 Basement, Greater Kailash-1, New Delhi 110048 Tel: 011 49057058
Email id: [email protected] ; Website: www.lalchandanipathlab.com
Company Secretary & Compliance Officer: Ms. Tanvi Malhotra

In order to repair debt, purchase of diagnostic equipment and machines, open more collection centers and other it support and operational expenses.


Dr Lalchandani Labs Limited – Financial Statements

A summary of the financial position of the company has been tabulated below:

Assets of the Company

Assets (in INR & Lakh)
 Mar’17Mar’16Mar’15Mar’14Mar’13
Total Assets376.39366.45187.16168.93165.22

Revenue & PAT of the Company

Revenue & Profits (in INR & Lakh)
 Mar’17Mar’16Mar’15Mar’14Mar’13
Total Revenue461.67 302.81 192.79 141.39 121.96
Profit after Tax (PAT)70.74 32.32 31.91 4.13 4.13

Earnings per Equity Share

Earning per Equity Share (in INR)
 Mar’17Mar’16Mar’15Mar’14Mar’13
Basic2.220.895.072.470.72
Diluted2.220.895.072.470.72

The financial performance of this company in terms of turnover / net profits for financial year – 2014, 2015, 2016 and 2017 is around Rs. 1.41 crore / Rs. 0.04 crore, Rs. 1.93 crore / Rs. 0.32 crore, Rs.3.03 crore / Rs. 0.32 crore and 4.62 crore / Rs. 0.71 crore respectively.


Dr Lalchandani Labs Limited Promoters

The Promoters of the Company:

  • Mr. Arjan Lal Chandani,
  • Mr. Mohit Lal Chandani, and
  • Mrs. Anchal Gupta

Payment or Benefit to Promoters of Our Company:

No payment has been made or benefit given to our Promoters in the two years preceding the date of the Prospectus or is intended to be given by us except mentioned / referred to in this Chapter and in page no. 173 under Related Party Transactions, under the Chapter “Financial Information of our company” of the Prospectus.

Interest in promotion of Our Company:

Our Promoters may be deemed to be interested in the promotion of the Issuer to the extent of the Equity Shares
held by themselves as well as their relative and also to the extent of any dividend payable to them and other
distributions in respect of the aforesaid Equity Shares. Further, our Promoters may also be interested to the
extent of Equity Shares held by or that may be subscribed by and allotted to companies and firms in whom either
of them is interested as a director, member or partner. In addition, our Promoters, being Directors may be
deemed to be interested to the extent of fees, if any, payable for attending meetings of the Board or a
committee thereof as well as to the extent of remuneration and reimbursement of expenses, if any, payable
under our Articles of Association and to the extent of remuneration, if any, paid for services rendered as an
officer or employee of our Company as stated in section titled “Our Management” on page 141 of this Draft
Prospectus.

Interest in the property of Our Company:

Our promoters do not have any other interest in any property acquired by our Company in a period of two years
before filing of this Draft Prospectus or proposed to be acquired by us till the date of filing the Draft Prospectus
with RoC.

Interest as Member of our Company:
As on the date of this Draft Prospectus, our Promoters and Promoter Group collectively hold 26,33,810 Equity
Shares of our Company and is therefore interested to the extent of their shareholding and the dividend declared,
if any, by our Company. Except to the extent of shareholding of the Promoter in our Company and benefits as
provided in the section titled ‘Terms of appointment and compensation of our Directors’ on page 143 of this
Draft Prospectus, our Promoters does not hold any other interest in our Company.

Also see “Our Management-Interest of Directors” on Page 148 of this Draft Prospectus.

 


Dr Lalchandani Labs IPO Offer Details or Issue Details

Particulars of the IssueNet Issue to PublicMarket Maker Reservation Portion
Number of Equity Shares
available for allocation
13,28,000 Equity Shares72,000 Equity Shares
Percentage of Issue Size
available for allocation
94.86% of the Issue size5.14% of the Issue size
Basis of AllotmentProportionate subject to minimum
allotment  of  4,000  Equity  Shares
and further allotment in multiples
of 4,000 Equity Shares each.For further details please refer to
the section titled “Issue Procedure
– Basis of Allotment” on page 243
of this Draft Prospectus.
Firm Allotment
Mode of ApplicationAll  the  applicants  shall  make  the
application  (Online  or  Physical)
through the ASBA Process
Through ASBA Process Only
Minimum  Application
Size
For QIB and NII:
Such  number  of  Equity  Shares  in
multiples  of  4,000  Equity  Shares
such  that  the  Application  Value
exceeds Rs.  2,00,000/-For Retail Individuals:
4,000 Equity Shares
72,000 Equity Shares
Maximum Application
Size
For QIB and NII:
Such  number  of  equity  shares  in
multiples  of  4,000  Equity  Shares
such  that  the  Application  Size
does not exceed 13,28,000 Shares.
For Retail Individuals:
4,000 Equity Shares
72,000 Equity Shares
Mode of AllotmentCompulsorily  in  Dematerialized
mode
Compulsorily  in
Dematerialized mode
Trading Lot4,000 Equity Shares4,000  Equity  Shares,
However  the  Market
Makers  may  accept  odd
lots if any in the market as
required  under  the  SEBI
(ICDR) Regulations, 2009.

 


Dr Lalchandani Labs IPO Issue Object

Dr Lalchandani Labs IPO proceeds are expected to be used for the following purposes:

  • Repayment or repayment of borrowed amount.
  • To open a processing center of 2000 square feet area in Delhi / NCR.
  • To develop a better IT support center and online application programs.
  • For corporate purpose.
  • To open collection center ( COCO model).
  • For purchasing advanced equipment and machines.

List of Upcoming IPOs in 2018

HDFC AMC IPONekkanti Seafoods IPODevi Seafoods IPOSandhya Marines IPO
John Energy IPOTCNS Clothing IPOSembCorp Energy IPOCredit Access Grameen IPO

Dr Lalchandani Labs IPO Basis for offer price

The Issue Price is determined by our Company in consultation with the Lead Manager on the basis of the following qualitative and quantitative factors. The face value of the Equity Share is Rs. 10 and Issue Price is Rs.30/- per Equity Share and is 3 times the face value.

Qualitative factors are:

Some of the qualitative factors, which form the basis for computing the price, are –

  • Business model focused on the patient as a customer and an established consumer healthcare brand
  • Strong financial position
  • Experienced leadership team with strong industry expertise

The relevant quantitative factors are:

  • Basic Earning Per Equity Share (EPS) (on Face value of Rs. 10 per share) as per Accounting Standard 20
  • Price / Earnings Ratio (P/E) in relation to the Issue Price Rs. 30.00
  • Return on Net Worth (RoNW)
  • Net Asset Value per Equity Share (NAV)
  • Minimum return on post Issue Net Worth to maintain the Pre-issue EPS for the period ended 31st January, 2018 is 5.84%.
  • Peer Group Comparison of Accounting Ratios

List of Latest IPOs of 2018

Fine Organic IPOIndoStar Capital IPOCapricorn Food Products IPOFlemingo Travel Retail IPO
Nazara Technologies IPOGenius Consultants IPORail Vikas Nigam IPOVerroc Engineering IPO

Dr Lalchandani Labs IPO Lead Managers

Lead Managers
Navigant Corporate Advisors Ltd

Dr Lalchandani Labs IPO Registrar to the Offer

Registrar of the Offer
Cameo Corporate Services Limited

Dr Lalchandani Labs IPO Review by Top 10 Stock Brokers

Top Stock Brokers ReviewCompany Repu-tationCompe-titive EdgeFinan-cial State-mentPopu-larity IndexPromo-ters Repu-tation
Angel Broking6.2/106.3/106.2/106.1/106.1/10
Sharekhan6.2/106.1/106.6/106.1/106.2/10
Kotak Securities6.3/106.2/106.3/106.1/106.3/10
ICICI Direct6.3/106.3/106.7/106.1/106.1/10
IIFL6.2/106.2/106.8/106.0/106.1/10
Edelweiss6.2/106.3/106.3/106.3/106.2/10
Zerodha6.3/106.1/106.2/106.1/106.0/10
5Paisa6.1/106.1/106.3/106.1/106.1/10
Karvy6.3/106.3/106.2/106.1/106.1/10
Motilal Oswal6.1/106.1/106.6/106.3/106.2/10

Dr Lalchandani Labs IPO Grey Market Premium

The Grey Market Premium are generally out before 1 week of IPO issue date but for SME Companies, Grey Market pricing are not considered.


Subscribe to Dr Lalchandani Labs IPO

Fill the Details Below
  1. Subscribe to IPOOpen Demat AccountBecome Sub Broker

Dr Lalchandani Labs IPO News

News 1 – Dr Lalchandani Labs Limited IPO starts now


Market Guide

What is IPO?
IPO Investment
IPO Valuation
Upcoming IPOs

Featured Topics

Featured Topics
Top 10 Discount Brokers in India
Top 10 Full Service Brokers in India
Top 10 Stock Brokers in India
Top 10 Intraday Trading Brokers in India
Best Demat Account in India
Stock Broker Comparison
Top 10 Broking Franchise
Sub Broker Franchise
Stock Market Franchise

 

Get 100% IPO Allotment Guarantee! Subscribe to IPO
error: Content is protected !!